Applications
RETINA's task-evoked measurement architecture can support research, cognitive performance, human performance, clinical development, future recovery-monitoring pathways, and future regulated applications, each with its own evidence requirements and claims boundary.
RetinaTek is building a platform for objective cognitive-performance measurement under controlled cognitive load. Some applications are available today through research and clinical-development deployments. Others are near-term commercial opportunities through RT-Focus. Additional clinical and platform markets will require further validation, partnerships, and regulatory clearance.
Not every application is at the same stage. RetinaTek separates current research use, near-term commercial cognitive-performance applications, clinical-development priorities, and future platform expansion.
Research and clinical-development deployments can use RETINA to evaluate objective neurocognitive endpoints, usability, workflow feasibility, longitudinal research protocols, and validation questions.
Examples
RT-Focus is RetinaTek's planned commercial product for supervised cognitive performance assessment in premium clinical and performance-oriented settings. RetinaTek is engaging FDA through the Q-submission process to confirm the appropriate regulatory pathway.
Examples
RT-Focus is not positioned as a diagnostic, screening, or disease-monitoring product.
RetinaTek is pursuing validation pathways for future regulated clinical applications, with an initial focus on adult and pediatric concussion/mTBI recovery-monitoring claims after validation and clearance.
Examples
Future clinical claims require appropriate validation and regulatory clearance.
As evidence, datasets, partnerships, and regulatory pathways mature, RETINA may support broader applications across safety-sensitive work, sports, biopharma, digital health, international markets, and AI/data partnerships.
These are potential future applications, not current diagnostic claims.
RETINA's value is strongest where objective, repeatable measurement under cognitive load can support research and future validated decisions about performance, recovery, treatment response, or readiness.
RETINA can support research teams that need objective, repeatable neurocognitive endpoints across attention, processing speed, cognitive control, effort, and performance consistency. Potential uses include endpoint development, longitudinal research measurement, treatment-response studies, and clinical trial protocols.
Discuss research deploymentRT-Focus is RetinaTek's planned commercial product for supervised cognitive performance assessment in premium clinical and performance-oriented settings, including concierge, executive, longevity, and preventive medicine. It creates a repeatable brain-performance baseline and repeat-measurement experience for members concerned with aging, focus, performance, cognitive change, and brain health.
RT-Focus is not positioned as a diagnostic, screening, or disease-monitoring product for MCI, Alzheimer's disease, dementia, or any other disease.
View RT-Focus previewMany patients want to know whether their cognitive performance is stable, improving, or changing over time. RT-Focus can support supervised cognitive baselining and repeat measurement in longevity and cognitive-aging workflows.
This is cognitive performance baselining and repeat measurement, not diagnosis, screening, or disease monitoring for dementia, MCI, Alzheimer's disease, or any other condition.
View RT-Focus previewRetinaTek's initial future regulated clinical-development focus is adult and pediatric concussion/mTBI, with emphasis on recovery-trajectory measurement after appropriate validation and clearance. After validation and clearance for the intended use, objective testing may help characterize whether a person is recovering as expected, plateauing, worsening, or likely to benefit from additional evaluation or intervention.
Future concussion/mTBI claims require appropriate validation and regulatory clearance.
Review clinical developmentRehabilitation is inherently longitudinal. RETINA may support research and future clinical-development work focused on cognitive-performance change over time in neurorehabilitation, vestibular rehab, stroke, acquired brain injury, and recovery-focused workflows.
May support research and future validated use cases involving treatment-response tracking, recovery trajectory assessment, and identification of patients who are not progressing as expected.
Contact the teamRETINA was shaped in military research environments and may support cognitive readiness, training readiness, blast exposure research, and human-performance studies. The platform is well suited to measuring cognitive performance under controlled demand.
Specific operational or medical claims require appropriate validation, use context, and regulatory treatment.
Contact the teamCNS trials often need objective, repeatable, low-burden measures of cognitive change. RETINA may support exploratory endpoints, secondary endpoints, trial enrichment, treatment-response studies, and decentralized or hybrid assessment workflows.
Use in clinical trials depends on protocol, endpoint strategy, validation requirements, and regulatory context.
Discuss research deploymentTask-evoked multimodal data may support future predictive models, longitudinal digital biomarkers, and integrations with hardware, clinical, research, and digital health platforms. These opportunities require appropriate consent, privacy controls, validation, and governance.
Contact the teamAdditional opportunities may emerge as the platform, evidence base, hardware ecosystem, and data infrastructure mature.
These are potential future areas and do not represent current diagnostic claims.
The same measurement architecture can be used in different contexts, but the claims are not the same. RetinaTek separates research use, cognitive-performance assessment, clinical-development work, and future regulated clinical indications.
Start with RT-Focus.
View RT-Focus previewStart with a research deployment.
Contact the teamStart with clinical-development collaboration.
Review Clinical DevelopmentStart with platform partnership.
Contact the teamStart with the platform thesis and evidence base.
Review EvidenceRetinaTek separates research use, planned cognitive-performance assessment, clinical-development work, and future regulated applications. Current public materials do not claim that RETINA or RT-Focus is FDA-cleared, FDA-approved, or authorized for diagnostic use. Disease-specific diagnostic or monitoring claims require appropriate validation, compliance review, and regulatory clearance where applicable.
RetinaTek is building a platform for objective cognitive-performance measurement under controlled cognitive load. We are interested in research deployments, premium clinical workflows, clinical-development partnerships, human-performance applications, and strategic platform collaborations.